Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: The impact of 5HT3RA antiemetics on the incidence of chemotherapy-induced nausea and vomiting (CINV), treatment adherence, and delay of therapy in early-stage breast cancer (BC) patients treated with moderately/highly emetogenic chemotherapy (MEC/HEC)., Journal of Clinical Oncology, September 2012, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2012.30.27_suppl.75.
You can read the full text:
Contributors
The following have contributed to this page
